Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Susan Bartlett Foote currently holds 21,540 shares of HAEMONETICS CORP (HAE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Susan Bartlett Foote has been a net seller of HAE stock. They have purchased $49.3K and sold $5.0M worth of shares.
Susan Bartlett Foote's most recent insider trade was on Nov 10, 2017, when they sold 100 shares at $54.26 per share.
Susan Bartlett Foote serves as Executive at HAEMONETICS CORP (HAE). They have executed 67 insider transactions totaling $5.0M over their tenure at the company.
Susan Bartlett Foote holds the position of Executive at HAEMONETICS CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
Susan Bartlett Foote has shown a selling trading pattern, with $49.3K in total purchases and $5.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Susan Bartlett Foote was on May 11, 2017, when they sold $639.8K worth of HAE shares. This transaction involved 15,314 shares at $41.78 per share.
Susan Bartlett Foote currently owns 21,540 shares of HAEMONETICS CORP (HAE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Susan Bartlett Foote's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Susan Bartlett Foote has 67 Form 4 filings on record as an insider at HAEMONETICS CORP.
Set alerts for Susan Bartlett Foote and 40,000+ other insiders.